Skip to main content

The leading infectious disease that kills people again is tuberculosis:

 Approximately 8.2 million people had a new TB diagnosis in 2023, the most since WHO started global TB monitoring in 1995, according to a new study on the disease released today by the World Health Organization (WHO). With a significant rise from the 7.5 million recorded in 2022, TB surpassed COVID-19 to reclaim its position as the most common infectious disease death in 2023.


The WHO's 2024 Global Tuberculosis Report outlines conflicting advancements in the worldwide battle against tuberculosis, with enduring obstacles such severe underfunding. The overall number of TB-related illnesses increased little to an anticipated 10.8 million in 2023, despite a decline in TB-related mortality from 1.32 million in 2022 to 1.25 million in 2023.


India (26%), Indonesia (10%), China (6.8%), the Philippines (6.8%), and Pakistan (6.3%) collectively accounted for 56% of the worldwide TB burden, with the disease disproportionately affecting individuals in 30 high-burden nations. The survey found that 33% of TB cases were in women, 12% were in children and young adolescents, and 55% of TB cases were in men.


"The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, stated, "It is shocking that TB still kills and sickens so many people when we have the means to prevent, detect, and treat it." "WHO calls on all nations to fulfill the specific pledges they have made to increase the use of those tools and eradicate tuberculosis."


From COVID-19 pandemic levels of approximately 4 million in 2020 and 2021, the difference between the estimated and reported number of new TB cases decreased to about 2.7 million in 2023. This comes after significant national and international efforts to recover from TB service delays caused by COVID. For those with HIV, the coverage of TB preventive therapy has been maintained, and it keeps becoming better for household connections of those with TB diagnoses.


Multidrug-resistant tuberculosis is still a public health emergency, nevertheless. Currently, 68% of patients with multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) have successfully completed treatment. However, only 44% of the anticipated 400 000 individuals with MDR/RR-TB received a diagnosis and treatment in 2023.


Funding shortages and difficulties:


In 2023, global spending for TB prevention and treatment fell even more, and it is still far below its goal. There were severe financing constraints in low- and middle-income countries (LMICs), which are responsible for 98% of the TB burden. In 2023, only US$5.7 billion, or 26% of the global target, of the US$22 billion annual financing target was available.


For a number of years, the annual total of international donor financing in LMICs has stayed between US$1.1 and US$1.2 billion. The biggest bilateral donor for tuberculosis is still the US government. Although the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is the largest international donor to the TB response, particularly in LMICs, resources are still insufficient to provide the basic demands for TB services. For TB prevention, diagnostic, and treatment initiatives to be successful, the research highlights the importance of consistent financial support.


Only one-fifth of the US$5 billion annual objective was met in 2022, indicating that TB research is still woefully underfunded globally. This hinders the creation of novel TB medications, vaccines, and diagnostics. With the help of the TB Vaccine Accelerator Council, which the WHO Director-General established, WHO is still spearheading initiatives to further the TB vaccine agenda.


Complex factors contributing to the epidemic:


Estimates of the proportion of TB-affected families in all LMICs that incur catastrophic expenses (over 20% of yearly household income) to obtain TB diagnosis and treatment are presented in the report for the first time. These show that half of households affected by tuberculosis have to deal with such devastating expenses.


Five main risk factors account for a sizable portion of newly diagnosed TB cases:


HIV infection, diabetes, alcoholism, smoking (particularly in men), and malnutrition. Coordinated multisectoral effort is needed to address these problems as well as important drivers like GDP per capita and poverty.


"Climate change, conflict, migration and displacement, pandemics, drug-resistant tuberculosis, a major contributor to antimicrobial resistance, and funding shortages and the devastating financial burden on those impacted are just a few of the many difficult issues we face," stated Dr. Tereza Kasaeva, Director of WHO's Global Tuberculosis Programme. "To address these urgent issues and increase our efforts, we must come together across all sectors and stakeholders."


Prior to the second UN High-Level Meeting in 2027, significant progress is required to meet additional targets, and global milestones and targets for lowering the TB disease burden are not on track. WHO urges governments, international partners, and funders to take immediate steps to implement the promises made at the UN High-Level Meeting on TB in 2023. To speed up development and meet the worldwide goals established for 2027, more money must be allocated to research, especially for novel TB vaccines.

Comments

Post a Comment

Popular posts from this blog

Any Level of Exercise Reduces Death Risk in Dementia Patients by 30%:

  Regardless of intensity, new research indicates that frequent physical activity following a dementia diagnosis may lower the chance of death by as much as 30%. Even very little amounts of physical activity can reduce the chance of death for those with dementia by up to 30% . The importance of promoting exercise in dementia patients is highlighted by a recent study, which found that benefits occur regardless of the intensity of the activity. According to research published online in the British Journal of Sports Medicine, engaging in physical activity of any intensity following a dementia diagnosis is linked to a roughly 30% lower chance of death. Given that the typical life expectancy following a dementia diagnosis may only be four to five years, the researchers conclude that persons who are affected should be encouraged to continue or begin an exercise regimen. Physical activity has been associated with a decreased risk of death in individuals with the condition in pre...
Post a Comment
Read more

The Ideal Time for Breakfast:

  Breakfast is regarded as the most significant meal of the day. However, did you realize that it can have an impact on your blood pressure? It's accurate! According to research, skipping breakfast increases the risk of hypertension, or high blood pressure. Therefore, a nutrient-dense breakfast may lower your blood pressure if you're among the approximately 50% of American adults who have high blood pressure."Eating breakfast gives the heart the vital nutrients it needs to function better, which improves blood pressure and vascular tone," explains Michelle Routhenstein, M.S., RD, CDCES, a registered dietitian with expertise in preventive cardiology. To get these advantages, however, how early must you eat breakfast? We consulted dietitians to determine when eating breakfast is most beneficial for people with high blood pressure. What they told us is as follows. The Ideal Breakfast Time for People with High Blood Pressure: To support good blood pressure, experts ad...
Post a Comment
Read more

Is coffee beneficial to heart health?

 Researchers have been examining coffee's effects on heart health because it's still one of the most popular drinks in the world. A number of recent studies have shown conflicting results, indicating that excessive caffeine consumption may be harmful while moderate coffee consumption may have protective effects. The possible effects of coffee on cardiovascular health have been clarified by recent research, igniting fresh curiosity and complex viewpoints. Regular coffee consumption reduces the risk of diabetes and heart disease: 200–300 mg of caffeine per day, or around two to three cups of coffee, may reduce the risk of type 2 diabetes , coronary heart disease, and stroke by up to 48% , according to a study published in the Journal of Clinical Endocrinology & Metabolism. While interventional cardiologist Dr. Cheng-Han Chen pointed out the potential advantages of coffee's other components, such as flavonoids and polyphenols, registered dietitian Melanie Murph...
Post a Comment
Read more